Barclays’s Change Healthcare Inc. Common Stock CHNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,700,687
| Closed | -$46.8M | – | 5622 |
|
|
2022
Q3 | $46.8M | Buy |
1,700,687
+1,481,700
| +677% | +$36.7M | 0.05% | 325 |
|
|
2022
Q2 | $5.05M | Sell |
218,987
-1,565,711
| -88% | -$36.6M | ﹤0.01% | 1328 |
|
|
2022
Q1 | $38.9M | Buy |
1,784,698
+1,242,594
| +229% | +$25.8M | 0.03% | 486 |
|
|
2021
Q4 | $11.6M | Buy |
542,104
+272,235
| +101% | +$5.71M | ﹤0.01% | 1191 |
|
|
2021
Q3 | $5.65M | Sell |
269,869
-304,368
| -53% | -$6.64M | ﹤0.01% | 1540 |
|
|
2021
Q2 | $13.2M | Sell |
574,237
-133,675
| -19% | -$3.07M | 0.01% | 1083 |
|
|
2021
Q1 | $15.6M | Buy |
707,912
+523,947
| +285% | +$12.1M | 0.01% | 895 |
|
|
2020
Q4 | $3.43M | Buy |
183,965
+169,473
| +1,169% | +$2.78M | ﹤0.01% | 1805 |
|
|
2020
Q3 | $210K | Sell |
14,492
-76,572
| -84% | -$974K | ﹤0.01% | 3817 |
|
|
2020
Q2 | $1.02M | Sell |
91,064
-655,720
| -88% | -$7.36M | ﹤0.01% | 2735 |
|
|
2020
Q1 | $7.46M | Buy |
746,784
+746,781
| +24,892,700% | +$10.4M | 0.01% | 1183 |
|
|
2019
Q4 | $0 | Sell |
3
-20,072
| -100% | -$269K | ﹤0.01% | 7007 |
|
|
2019
Q3 | $243K | Sell |
20,075
-429,925
| -96% | -$5.91M | ﹤0.01% | 4831 |
|
|
2019
Q2 | $6.57M | Buy |
+450,000
| New | +$6.66M | ﹤0.01% | 1621 |
|
Other funds holding CHNG
Barclays's CHNG Position: Q4 2022 in Review
Barclays sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 1,700,687 shares — an estimated $46.8M sold.
Barclays first reported a position in CHNG in Q2 2019 and held it in 14 quarters. The position peaked at $46.8M in Q3 2022. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.
- Barclays reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- Barclays sold 1,700,687 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $46.8M.
- Barclays first reported a position in Change Healthcare Inc. Common Stock in Q2 2019 and held it in 14 quarters.
- Barclays's Change Healthcare Inc. Common Stock position peaked at $46.8M in Q3 2022.
- 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.